Data standards in drug discovery: A long way to go

Drug Discov Today. 2024 Feb;29(2):103879. doi: 10.1016/j.drudis.2024.103879. Epub 2024 Jan 11.ABSTRACTEach year, millions to trillions of data points are generated to evaluate the response of chemicals and biologicals to human cells in vitro and in vivo using various technologies and endpoints. Despite the vast amount of data available, the development process has not become significantly more efficient in recent years. Given the increasing use of more complex physiological models, which are time-consuming and significantly more expensive, it is crucial to maximize the value of these valuable data through improved standardization.PMID:38216119 | DOI:10.1016/j.drudis.2024.103879
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research